IL10 and non-Hodgkin lymphoma: Some studies have illustrated that the IL-10 rs1800896 polymorphism was correlated with enhanced risk of nasopharyngeal carcinoma [25] and gastric cancer [26], diabetic nephropathy [27], and non-Hodgkin's lymphoma [28].